13 sett 2017 anni - Potential for use of macrocyclic peptide encompassing
the L2 loop sequence from HHIP to disrupt SHH binding
as a therapy.
Descrizione:
Design and Evolution of a Macrocyclic Peptide Inhibitor of the Sonic Hedgehog pathway
Aggiunto al nastro di tempo:
Data:
~ 6 years and 8 months ago